Login
$LIVN
$92.44 +$1.12 (1.23%) Live

$LIVN 8-K SEC Filings

Filed On Filing
04 Nov 2026 8-K: Results of Operations and Financial Condition

LivaNova Reports Third-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance

05 Aug 2026 8-K: Results of Operations and Financial Condition

LivaNova Reports Second-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance

11 Jun 2026 8-K: Submission of Matters to a Vote of Security Holders

LivaNova PLC (the “Company” or “LivaNova”) held its 2026 Annual General Meeting of Shareholders (the “AGM”) on June 10, 2026. At the AGM, LivaNova’s shareholders considered 10 proposals as more fully described in the Company’s definitive...

06 May 2026 8-K: Results of Operations and Financial Condition

LivaNova Reports First-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance

25 Feb 2026 8-K: Results of Operations and Financial Condition

LivaNova Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Guidance

14 Jan 2026 8-K: Departure/Election of Directors or Officers; Compensation
05 Nov 2025 8-K: Results of Operations and Financial Condition

LivaNova Reports Third-Quarter 2025 Results; Raises 2025 Guidance

04 Sep 2025 8-K: Departure/Election of Directors or Officers; Compensation
06 Aug 2025 8-K: Results of Operations and Financial Condition

LivaNova Reports Second-Quarter 2025 Results; Raises 2025 Guidance

11 Jun 2025 8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders

SECOND AMENDED AND RESTATED LIVANOVA PLC 2022 INCENTIVE AWARD PLAN (Adopted by the Board of Directors of LivaNova PLC on April 23, 2025, conditional on shareholder approval.) (Approved by the shareholders of LivaNova PLC on June 11, 2025...

21 May 2025 8-K: Regulation FD Disclosure

As previously disclosed, LivaNova PLC (the “Company”) has been engaged in a civil action whereby the Court of Appeal of Milan (the “Court of Appeal”) previously declared the Company (formed through a merger with Sorin) jointly and severa...

07 May 2025 8-K: Results of Operations and Financial Condition

LivaNova Reports First-Quarter 2025 Results; Updates 2025 Guidance

17 Mar 2025 8-K: Regulation FD Disclosure

As previously disclosed, LivaNova PLC (the “Company”) has been engaged in a civil action whereby the Court of Appeal of Milan previously declared the Company (formed through a merger with Sorin) jointly and severally liable with SNIA (a ...

25 Feb 2025 8-K: Results of Operations and Financial Condition

London, February 25, 2025 – LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported fourth-quarter and full-year 2024 results and issued full-year 2025 guidance.

01 Nov 2024 8-K: Regulation FD Disclosure

On November 1, 2024, the U.S. Centers for Medicare and Medicaid Services (CMS) announced that it is maintaining VNS Therapy™ for drug-resistant epilepsy (DRE) at the Level 5 Neurostimulator and Related Procedures Ambulatory Payment Class...

30 Oct 2024 8-K: Results of Operations and Financial Condition

London, October 30, 2024 – LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the quarter ended September 30, 2024 and raised full-year 2024 guidance.

08 Oct 2024 8-K: Departure/Election of Directors or Officers; Compensation
10 Sep 2024 8-K: Departure/Election of Directors or Officers; Compensation
31 Jul 2024 8-K: Results of Operations and Financial Condition

London, July 31, 2024 – LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the quarter ended June 30, 2024 and raised full-year 2024 revenue and adjusted diluted earnings per share guidance.

12 Jun 2024 8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders

Amendment No. 2 to the LivaNova PLC 2015 Incentive Award Plan WHEREAS, LivaNova PLC (the “Company”) maintains the LivaNova PLC 2015 Incentive Award Plan (as amended, the “2015 Plan”) for the purpose of granting equity awards to Non-Emplo...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support